Androgens, health and sexuality in women and men

Human Fertility

Volumn 13, Issue 4, 2010, Pages 277-297

  Wylie, Kevan ^a   Rees, Margaret ^b,c,d,e,f   Hackett, Geoff ^g   Anderson, Richard ^h   Bouloux, Pierre Marc ⁱ   Cust, Mike ^j   Goldmeier, David ^k   Kell, Philip ^l   Terry, Tim ^c   Trinick, Tom ^m,n   Wu, Frederick ^o  

^a Porterbrook Clinic   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Department of Medical Gynaecology ^*  (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e University of Medicine   (Australia)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^j ROYAL DERBY HOSPITAL   (United Kingdom)

^k Jane Wadsworth Sexual Function Clinic   (United Kingdom)

^l TORBAY AND SOUTH DEVON NHS FOUNDATION TRUST   (United Kingdom)

^m ULSTER HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY OF ULSTER   (United Kingdom)

^o UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

Androgens; desire disorder; fertility; sexuality; testosterone; well being

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL PLUS METHYLTESTOSTERONE; FOLLITROPIN; GESTAGEN; LUTEINIZING HORMONE; METHYLTESTOSTERONE; NORETHISTERONE ACETATE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PRASTERONE; PROLACTIN; STEROID; TESTOSTERONE; TIBOLONE;

ACNE; ADRENAL INSUFFICIENCY; ALCOHOL CONSUMPTION; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; ANDROSTENEDIONE BLOOD LEVEL; ARTHRITIS; BREAST CANCER; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONSULTATION; DEPRESSION; DIABETES MELLITUS; DRUG MEGADOSE; DYSPAREUNIA; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; ERYTHROCYTOSIS; FEMALE FERTILITY; FEMALE SEXUAL DYSFUNCTION; HEALTH; HEMATOCRIT; HIRSUTISM; HORMONAL THERAPY; HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; HYSTERECTOMY; INSOMNIA; LIBIDO DISORDER; LIFE STRESS; LIVER TOXICITY; LONG TERM CARE; LOW DRUG DOSE; MALE FERTILITY; MALE SEXUAL DYSFUNCTION; MEDICAL ASSESSMENT; MENOPAUSE; METABOLIC SYNDROME X; MONITORING; NYMPHOMANIA; OBESITY; OVARIECTOMY; PRACTICE GUIDELINE; PROLACTINOMA; PROSTATE CANCER; PROSTATE CARCINOMA; RENAL DIABETES; REVIEW; RISK FACTOR; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUALITY; SIDE EFFECT; SLEEP APNEA SYNDROME; SUBSTITUTION THERAPY; TESTOSTERONE BLOOD LEVEL; UNITED KINGDOM; VAGINA ATROPHY; VAGINISM; VASOMOTOR DISORDER; VIRILIZATION; WELLBEING;

ANDROGENS; FEMALE; FERTILITY; HUMANS; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUALITY; TESTOSTERONE;

EID: 78649940277     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.3109/14647273.2010.530966     Document Type: Review

References (150)

1. Agarwal, P.K., & Oefelein, M.G. (2005). Testosterone replacement therapy after primary treatment for prostate cancer. Journal of Urology, 173, 533-536.
2. Allan, C.A., Strauss, B.J., Burger, H.G., Forbes, E.A., & McLachlan, R.I. (2008). Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in non obese aging men. Journal of Clinical Endocrinology and Metabolism, 93, 139-146.
3. Allan, C.A., Strauss, B.J., & McLachlan, R.I. (2007). Body composition, metabolic syndrome and testosterone in ageing men. International Journal of Impotence Research, 19, 448-457.
4. Araujo, A.B., Esche, G.R., Kupelian, V., ODonnell, A.B., Travison, T.G., Williams, R.E., et al. (2007). Prevalence of symptomatic androgen deficiency in men. Journal of Clinical Endocrinology and Metabolism, 92, 4241-4247.
5. Araujo, A.B., ODonnell, A., Brambilla, D.J., Simpson, W.B., Longcope, C., Matsumoto, A.M., et al. (2004). Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts male aging study. Journal of Clinical Endocrinology and Metabolism, 89, 5920-5926.
6. Aziz, A., Brannstrom, M., Bergquist, C., & Silfverstolpe, G. (2005). Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertility and Sterility, 83, 1021-1028.
7. Bachmann, G., Bancroft, J., Braunstein, G., Burger, H., Davis, S., Dennerstein, L., et al. (2002). Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertility and Sterility, 77, 660-665.
8. Barad, D., Brill, H., & Gleicher, N. (2007). Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. Journal of Assisted Reproduction and Genetics, 24, 629-634.
9. Barrett-Connor, E., Young, R., Notelovitz, M., Sullivan, J., Wiita, B., Yang, H.M., et al. (1999). A two year double blind comparison of oestrogen-androgen and conjugated oestrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. Journal of Reproductive Medicine, 44, 1012-1020.
10. Basson, R. (2001). Female sexual response: the role of drugs in the management of sexual dysfunction. Obstetrics and Gynecology, 98, 350-353.
11. Basson, R. (2008). Womens sexual function and dysfunction: current uncertainties, future directions. International Journal of Impotence Research, 20, 466-478.
12. Basson, R., Berman, J., Burnett, A., Derogatis, L., Ferguson, D., Fourcroy, J., et al. (2000). Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. Journal of Urology, 163, 888-893.
13. Basson, R., Brotto, L.A., Laan, E., Redmond, G., & Utian, W.H. (2005). Assessment and management of womens sexual dysfunctions: problematic desire and arousal. Journal of Sexual Medicine, 2, 291-300.
14. Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S., et al. (2006). Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91, 1995-2010.
15. Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S., et al. (2010). Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 95, 2536-2559.
16. Bhasin, S., Enzlin, P., Coviello, A., & Basson, R. (2007). Sexual dysfunction in men and women with endocrine disorders. Lancet, 369(9561), 597-611.
17. Black, A.M., Day, A.G., & Morales, A. (2004). The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? BJU International, 94, 1066-1070.
18. Brand, J.S., & Van Der Schouw, Y.T. (2010). Testosterone, SHBG and cardiovascular health in post-menopausal women. International Journal of Impotence Research, 22, 91-104.
19. Braunstein, G.D. (2007). Safety of testosterone treatment in postmenopausal women. Fertility and Sterility, 88, 1-17.
20. Braunstein, G.D., Sundwall, D.A., Katz, M., Shifren, J.L., Buster, J.E., Simon, J.A., et al. (2005). Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women. Archives of Internal Medicine, 165, 1582-1589.
21. Brock, G., Nicolosi, A., Glasser, D.B., Gingell, C., & Buvat, J. (2002). Sexual problems reported by men and women in 28 countries: results of the global study of sexual attitudes and behaviours. International Journal of Impotence Research, 14, S57-S58.
22. Bü chter, D., Behre, H.M., Kliesch, S., & Nieschlag, E. (1998). Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. European Journal of Endocrinology, 139, 298-303.
23. Bunch, T.J., Abraham, D., Wang, S., & Meikle, A.W. (2002). Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction. The Aging Male, 5, 38-46.
24. Burger, G.H., Hailes, J., Menelaus, M., Nelson, J., Hudson, B., & Balazs, N. (1984). The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical lipid and hormonal results. Maturitas, 6, 351-358.
25. Burger, H., Hailes, J., Nelson, J., & Menelaus, M. (1987). Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. BMJ, 294, 936-937. (Pubitemid 17051529)
26. Burris, A.S., Clark, R.V., Vantman, D.J., & Sherins, R.J. (1988). A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertility and Sterility, 50, 343-347.
27. Buster, J.E., Kingsberg, S.A., Aguirre, O., Brown, C., Breaux, J.G., Buch, A., et al. (2005). Testosterone patch for low sexual desire in surgically menopausal women: a randomised trial. Obstetrics and Gynecology, 105, 944-952.
28. Buvat, J., & Bou Jaoudé, G. (2006). Significance of hypogonadism in erectile dysfunction. World Journal of Urology, 24, 657-667.
29. Buvat, J., & Lemaire, A. (1997). Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. Journal of Urology, 158, 1764-1767.
30. Buvat, J., Maggi, M., Gooren, L., Guay, A.T., Kaufman, J., Morgentaler, A., et al. (2010). Endocrine aspects of male sexual dysfunctions. Journal of Sexual Medicine, 7, 1627-1656.
31. Calof, O.M., Singh, A.B., Lee, M.L., Kenny, A.M., Urban, R.J., Tenover, J.L., et al. (2005). Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 60, 1451-1457.
32. Carpenter, W.R., Robinson, W.R., & Godley, P.A. (2008). Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer. Journal of the National Cancer Institute, 100, 158-159.
33. Chudakov, B., Ben Zion, I.Z., & Belmaker, R.H. (2007). Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the Arizona Sexual Experiences Scale for Females and Sexual Function Questionnaire. Journal of Sexual Medicine, 4, 204-208.
34. Citron, J.T., Ettinger, B., Rubinoff, H., Ettinger, V.M., Minkoff, J., Hom, F., et al. (1996). Prevalence of hypothalamicpituitary imaging abnormalities in impotent men with secondary hypogonadism. Journal of Urology, 155, 529-533.
35. Clayton, A.H. (2003). Sexual function and dysfunction in women. The Psychiatric Clinics of North America, 26, 673-678.
36. Clayton, A.H., Goldfischer, E.R., Goldstein, I., DeRogatis, L., Lewis-DAgostino, D., & Pyke, R. (2009). Validation of the Decreased Sexual Desire Screener(DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). Journal of Sexual Medicine, 6, 730-738.
37. Dabbs, M., & Dabbs, J.M. (2000). Heroes, rogues, and lovers: testosterone and behavior. New York: McGraw-Hill.
38. Davis, S.R. (2002). The effects of tibolone on mood and libido. Menopause, 9, 162-170.
39. Davis, S.R., Davison, S.L., Donath, S., & Bell, R.J. (2005). Circulating androgen levels and self-reported sexual function in women. JAMA, 294, 91-96. (Pubitemid 41002843)
40. Davis, S.R., McCloud, P., Strauss, B.J., & Burger, H. (1995). Testosterone enhances oestradiols effects on postmenopausal bone density and sexuality. Maturitas, 21, 227-236.
41. Davis, S.R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., et al. (2008). Testosterone for low libido in post menopausal women not taking estrogen. New England Journal of Medicine, 359, 2005-2017.
42. Davison, S., Bell, R., Donath, S., Montalto, J.G., & Davis, S.R. (2005). Androgen levels in adult females: changes with age, menopause and oophorectomy. Journal of Clinical Endocrinology and Metabolism, 90, 3847-3853.
43. Dennerstein, L., Hayes, R., Sand, M., & Lehert, P. (2009). Attitudes toward and frequency of partner interactions among women reporting decreased sexual desire. Journal of Sexual Medicine, 6, 1668-1673.
44. Dennerstein, L., Randolph, J., Taffe, J., Dudley, E., & Burger, H. (2002). Hormones, mood, sexuality and the menopause transition. Fertility & Sterility, 77(Suppl. 4), S42-S48.
45. Derby, C.A., Zilber, S., Brambilla, D., Morales, K.H., & McKinlay, J.B. (2006). Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts male ageing study. Clinical Endocrinology (Oxford), 65, 125-131.
46. Derogatis, L., Rust, J., Golombok, S., Bouchard, C., Nachtigall, L., Rodenberg, C., et al. (2004). Validation of the profile of female sexual function (PFSF) in surgically and naturally menopausal women. Journal of Sex & Marital Therapy, 30, 25-36.
47. Dobs, A.S., Nguyen, T., Pace, C., & Roberts, C.P. (2002). Differential effects of oral estrogen versus oral estrogen- androgen replacement therapy on body composition in post menopausal women. Journal of Clinical Endocrinology and Metabolism, 87, 1509-1516.
48. Dow, M.G., Hart, D.M., & Forrest, C.A. (1983). Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. British Journal of Obstetrics and Gynaecology, 90, 361-366.
49. Drinka, P.J., Jochen, A.L., Cuisinier, M., Bloom, R., Rudman, I., & Rudman, D. (1995). Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. Journal of the American Geriatrics Society, 43, 899-901.
50. Farquhar, C.M., Harvey, S.A., Yu, Y., Sadler, L., & Stewart, E.W. (2006). A prospective study of three years of outcomes after hysterectomy with and without oophorectomy. American Journal of Obstetrics and Gynecology, 194, 714-717.
51. Floter, A., Nathorst-Boos, J., Carlstrom, K., & von Schoultz, B. (2002). Addition of testosterone to estrogen replacement therapy in oophorectomised women: effects on sexuality and wellbeing. Climacteric, 5, 357-365.
52. Freitas, S.S., Barrett-Connor, E., Ensrud, K.E, Fink, H.A., Bauer, D.C., Cawthon, P.M., et al. (2007). Rate and circumstances of clinical vertebral fractures in older men. Osteoporosis International, 19, 615-623.
53. Gelfand, M.M., & Witta, B. (1997). Androgen and estrogen- androgen hormone replacement therapy: a review of the safety literature, 1941-1996. Clinical Therapeutics, 19, 383-404.
54. Goldfischer, E.R., Clayton, A.H., Goldstein, I., Lewis-DAgostino, D., & Pyke, R. (2008). Decreased Sexual Desire Screener(DSDS) for diagnosis of Hypoactive Sexual Desire Disorder in women. Obstetrics and Gynecology, 111, 109S.
55. Gooren, L.J. (2010). Androgens and male aging: current evidence of safety and efficacy. Asian Journal of Andrology, 12, 136-151.
56. Goto, M., Piper Hanley, K., Marcos, J., Wood, P.J., Wright, S., Postle, A.D., et al. (2006). In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. Journal of Clinical Investigation, 116, 953-960.
57. Graziottin, A. (2007). Prevalence and evaluation of sexual health problems - HSDD in Europe. Journal of Sexual Medicine, 4(Suppl. 3), 211-219.
58. Graziottin, A., Koochaki, P.E., Rodenberg, C., & Dennerstein, L. (2009). The prevalence of hypoactive sexual desire disorder in surgically menopausal women: an epidemiological study of women in four European countries. Journal of Sexual Medicine, 6, 2143-2153.
59. Greco, E.A., Spera, G., & Aversa, A. (2006). Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. European Urology, 50, 940-947.
60. Guay, A., Jacobson, J., Munarriz, R., Traish, A., Talakoub, L., Quirk, F., et al. (2004). Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. International Journal of Impotence Research, 16, 121-129. (Pubitemid 38579456)
61. Gurnell, E.M., Hunt, P.J., Curran, S.E., Conway, C.L., Pullenayegum, E.M., Huppert, F.A., et al. (2008). Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. Journal of Clinical Endocrinology and Metabolism, 93, 400-409.
62. Hackett, G., Kell, P., Ralph, D., Dean, J., Price, D., Speakman, M., et al. (2008). British Society for Sexual Medicine guidelines on the management of erectile dysfunction. Journal of Sexual Medicine, 5, 1841-1865.
63. Harsh, V., McGarvey, E.L., & Clayton, A.H. (2008). Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot study. Journal of Sexual Medicine, 5, 640-645.
64. Hayes, R.D., Dennerstein, L., Bennett, C.M., Koochaki, P.E., Leiblum, S.R., & Graziottin, A. (2007). Relationship between hypoactive sexual desire disorder and aging. Fertility and Sterility, 87, 107-112.
65. Kalyani, R.R., & Dobs, A.S. (2007). Androgen deficiency, diabetes, and the metabolic syndrome in men. Current Opinion in Endocrinology, Diabetes, and Obesity, 14, 226-234.
66. Kapoor, D., Aldred, H., Clark, S., Channer, K.S., & Jones, T.H. (2007a). Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care, 30, 911-917.
67. Kapoor, D., Channer, K., Aldred, H., Hugh Jones, T., & Clark, S. (2007b). Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes. Diabetes Care, 30, 911-917.
68. Kenny, A.M., Prestwood, K.M., & Raisz, L.G. (2000). Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels. Endocrine Research, 26, 153-168.
69. Khera, M., & Lipshultz, L.I. (2007). The role of testosterone replacement therapy following radical prostatectomy. The Urologic Clinics of North America, 34, 549-553, vi.
70. Kingsberg, S. (2007). Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. Journal of Sexual Medicine, 4(Suppl. 3), 227-234.
71. Kingsberg, S., Shifren, J., Wekselman, K., Rodenberg, C., Koochaki, P., & Derogatis, L. (2007). Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in post menopausal women with hypoactive sexual desire disorder. Journal of Sexual Medicine, 4, 1001-1008.
72. Krapf, J.M., & Simon, J.A. (2009). The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas, 63, 213-219.
73. Kupelian, V., Page, S.T., Araujo, A.B., Travison, T.G., Bremner, W.J., & McKinlay, J.B. (2006). Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology and Metabolism, 91, 843-850.
74. Labrie, F., Belanger, A., Labrie, C., Candas, B., Cusan, L., & Gomez, J.L. (2007). Bioavailability and metabolism of oral and percutaneous dihydroepiandrosterone in postmenopausal women. Journal of Steroid Biochemistry & Molecular Biology, 107, 57-69. (Pubitemid 47362670)
75. Labrie, F., Luu-The, V., Belanger, A., Lin, S-X., Simard, J., Pelletier, G., et al. (2005). Is dihydroepiandrosterone a hormone? Journal of Endocrinology, 187, 169-196.
76. Laumann, E.O., Paik, A., & Rosen, R.C. (1998). Sexual dysfunction in the United States: prevalence and predictors. JAMA, 281, 537-544.
77. Leiblum, S.R., Koochaki, P.E., Rodenberg, C.A., Barton, I.P., & Rosen, R.C. (2006). Hypoactive sexual desire disorder in postmenopausal women: US results from the Womens International Study of Health and Sexuality (WISHeS). Menopause, 13, 46-56.
78. Lindau, S.T., Schumm, L.P., Laumann, E.O., Levinson, W., OMuircheartaigh, C.A., & Waite, L.J. (2007). A study of sexuality and health among older adults in the United States. New England Journal of Medicine, 357, 762-774.
79. Liu, P.Y., Baker, H.W., Jayadev, V., Zacharin, M., Conway, A.J., & Handelsman, D.J. (2009). Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropindeficient infertile men: predictors of fertility outcome. Journal of Clinical Endocrinology and Metabolism, 94, 801-808.
80. Lobo, R.A., Rosen, R.C., Yang, H.M., Block, B., & van Der Hoop, R.G. (2003). Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in post menopausal women with hypoactive sexual desire. Fertility and Sterility, 79, 1341-1352.
81. Mazer, N.A. (2009). A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids, 74, 512-519.
82. Mazer, N.A., Leiblum, S.R., & Rosen, R.C. (2000). The Brief Index of Sexual Functioning for Women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause, 7, 350-363.
83. Mercer, C.H., Fenton, K.A., Johnson, A.M., Wellings, K., Macdowall, W., McManus, S., et al. (2003). Sexual function problems and help seeking behaviour in Britain: national probability sample survey. BMJ, 327, 426-427.
84. Mimoun, S., & Wylie, K. (2009). Female sexual dysfunctions: definitions and classification. Maturitas, 63, 116-118.
85. Morales, A., Schulman, C.C., Tostain, J., & Wu, C.W. (2006). Testosterone deficiency syndrome (TDS) needs to be named appropriately the importance of accurate terminology. European Urology, 50, 407-409.
86. Moreira, E.D., Glasser, D.B., Nicolosi, A., Duarte, F.G., & Gingell, C.; GSSAB Investigators Group. (2008). Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU International, 101, 1005-1011.
87. Nathorst Boos, J., Floter, A., Jarkander Rolff, M., Carlstrom, K., & Schoultz, B. (2006). Treatment with percutaneous testosterone gel in post menopausal women with decreased libido effects on sexuality and psychological well-being. Maturitas, 53, 11-18.
88. Ness, R.B., Albano, J.D., McTiernan, A., & Cauley, J.A. (2009). Influence of estrogen plus testosterone supplementation on breast cancer. Archives of Internal Medicine, 169, 41-46.
89. Nieschlag, E. (2006). Testosterone treatment comes of age: new options for hypogonadal men. Clinical Endocrinology (Oxford), 65, 275-281.
90. Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al. (2005a). Investigation, treatment and monitoring of late-onset hypogonadism in males. The Aging Male, 8, 56-58.
91. Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al. (2005b). Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. International Journal of Andrology, 28, 125-127. (Pubitemid 40780337)
92. Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al. (2005c). Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. European Urology, 48, 1-4. (Pubitemid 40835584)
93. Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al. (2006). Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU Recommendations. Journal of Andrology, 27, 135-137.
94. Nijland, E.A., Weijmar Schultz ,W.C., Nathorst-Boös, J., Helmond, F.A., Van Lunsen, R.H., Palacios, S., et al. (2008). Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. Journal of Sexual Medicine, 5, 646-656.
95. North American Menopause Society. (2005). The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society. Menopause, 12, 496-511.
96. North American Menopause Society. (2010). Estrogen and progesterone use in post menopausal women: 2010 position statement of the North American Menopause Society. Menopause, 17, 242-255.
97. Paik, A., & Laumann, E.O. (2006). Prevalence of womens sexual problems in the USA. In I. Goldstein, C. Meston, S.R. Davis, A.M., & Traish (Eds), Womens sexual function and dysfunction: study, diagnosis and treatment. London: Taylor & Francis.
98. Panjari, M., Bell, R.J., Jane, F., Adams, J., Morrow, C., & Davis,S.R. (2009). The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas, 63, 240-245.
99. Panjari, M., & Davis, S.R. (2007). DHEA therapy for women: effect on sexual function and wellbeing. Human Reproduction Update, 13, 239-248.
100. Panjari, M., & Davis, S.R. (2010). DHEA for postmenopausal women: a review of the evidence. Maturitas, 66, 172-179.
101. Parasrampuria, J., Schwarz, K., & Petesch, R. (1998). Quality control of dihydroepiandrosterone dietary supplement products. JAMA, 280, 1565.
102. Parsons, J.K., Carter, H.B., Platz, E.A.,Wright, E.J., Landis, P., & Metter, E.J. (2005). Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiology, Biomarkers & Prevention, 14, 2257-2260.
103. Pitkin, J., & Rees, M.; British Menopause Society Council. (2008). Urogenital atrophy. Menopause International, 14, 136-137.
104. Rhoden, E.L., Estrada, C., Levine, L., & Morgentaler, A. (2003). The value of pituitary magnetic resonance imaging in men with hypogonadism. Journal of Urology, 170, 795-798.
105. Roddam, A.W., Allen, N.E., Appleby, P., & Key, T.J. (2008). Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. Journal of the National Cancer Institute, 100, 170-183.
106. Rosen, R., Brown, C., Leiblum, S., Heiman, J., Meston, C., Shabsigh, R., et al. (2000). Female sexual function index. Journal of Sex & Marital Therapy, 26, 191-208.
107. Rosner, W., Auchus, R.J., Azziz, R., Sluss, P.M., & Raff, H. (2007). Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism, 92, 405-413.
108. Santen, R.J., Allred, D.C., Ardoin, S.P., Archer, D.F., Boyd, N., Braunstein, G.D., et al. (2010). Postmenopausal hormone therapy: an Endocrine Society Scientific Statement. Journal of Clinical Endocrinology and Metabolism, 95(Suppl. 1), S1-S66.
109. Santoro, N., Torrens, J., Crawford, S., Allsworth, J.E., Finkelstein, J.S., Gold, E.B., et al. (2005). Correlates of circulating androgens in mid-life women: the Study of Womens Health across the Nation (SWAN). Journal of Clinical Endocrinology and Metabolism, 90, 4836-4845.
110. Sarosdy, M.F. (2007). Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer 109, 536-541.
111. Sarrel, P., Dobay, B., & Wilta, B. (1998). Estrogen and estrogen androgen replacement in postmenopausal women dissatisfied with estrogen only therapy. Sexual behaviour and neuroendocrine responses. Journal of Reproductive Medicine, 43, 847-856.
112. Schousboe, J.T., Taylor, B.C., Fink, H.A., Kane, R.L., Cummings, S.R., Orwoll, E.S., et al. (2007). Cost effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA, 298, 629-637.
113. Schover, L.R. (2008). Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk? Fertility and Sterility, 90, 129-140.
114. Shabsigh, A., Kang, Y., Shabsign, R., Gonzalez, M., Liberson, G., Fisch, H., et al. (2005). Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. Journal of Sexual Medicine, 2, 716-721.
115. Shabsigh, R., Crawford, E.D., Nehra, A., & Slawin, K.M. (2008). Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. International Journal of Impotence Research, 21, 9-23.
116. Shabsigh, R., Kaufman, J.M., Steidle, C., & Padma-Nathan, H. (2004). Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. Journal of Urology, 172, 658-663.
117. Sherwin, B.B., Gelfand, M.M., & Brender, W. (1985). Androgen enhances sexual motivation in females: a prospective crossover study of sex steroid administration in the surgical menopause. Psychosomatic Medicine, 47, 339-351.
118. Shifren, J.L., & Avis, N.E. (2007). Surgical menopause: effects on psychological well-being and sexuality. Menopause, 14, 586-591.
119. Shifren, J.L., Braunstein, G.D., Simon, J.A., Casson, P.R., Buster, J.E., Redmond, G.P., et al. (2000). Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New England Journal of Medicine, 343, 682-688.
120. Shifren, J.L., Monz, B.U., Russo, P.A., Segreti, A., & Johannes, C.B. (2008). Sexual problems and distress in United States women: prevalence and correlates. Obstetrics and Gynecology, 112, 970-978.
121. Shufelt, C.L., & Braunstein, G.D. (2008). Testosterone and the breast. Menopause International, 14, 117-122.
122. Shufelt, C.L., & Braunstein, G.D. (2009). Safety of testosterone use in women. Maturitas, 63, 63-66.
123. Silvain, M. (2009). Sexual response models in women. Maturitas, 63, 112-115.
124. Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S., et al. (2005). Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. Journal of Clinical Endocrinology and Metabolism, 90, 5226-5233.
125. Somboonporn, W., Bell, R.J., & Davis, S.R. (2005). Testosterone for peri and postmenopausal women. Cochrane Database of Systematic Reviews, 4, Art. No.: CD004509; doi: 10.1002/ 14651858.CD004509.pub2.
126. Spencer, J.B., Klein, M., Kumar, A., & Azziz, R. (2007). The geassociated decline of androgens in reproductive age and menopausal Black and White women. Journal of Clinical Endocrinology and Metabolism, 92, 4730-4733.
127. Swerdloff, R.S., & Wang, C. (2008). Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence. Clinical Chemistry, 54, 458-460.
128. Tamimi, R.M., Hankinson, S.E., Chen, W.Y., Rosner, B., & Colditz, G.A. (2006). Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Archives of Internal Medicine, 166, 1483-1489.
129. Teplin, V., Vittinghoff, E., Lin, F., Learman, L.A., & Richter, H.E., & Kuppermann, M. (2007). Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Obstetrics and Gynecology, 109, 347-354. (Pubitemid 46197427)
130. Thom, M.H., Collins, W.P., & Studd, J.W. (1981). Hormonal profiles in postmenopausal women after therapy with subcutaneous implants. British Journal of Obstetrics and Gynaecology, 88, 426-433.
131. Thompson, I.M., Ankerst, D.P., Chi, C., Goodman, P.J., Tangen, C.M., Lucia, M.S., et al. (2006a). Assessing prostate cancer risk: results from the prostate cancer prevention trial. Journal of the National Cancer Institute, 98, 529-534. (Pubitemid 43898816)
132. Thompson, I.M., Carroll, P.R., & Carducci, M.A. (2006b). Recommendations for defining and treating high risk localized prostate cancer. Journal of Urology, 176, S6-S10.
133. van der Stege, J.G., Groen, H., van Zadelhoff, S.J., Lambalk, C.B., Braat, D.D., van Kasteren, Y.M., et al. (2008). Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause, 15, 23-31.
134. Van Staa, T.P., & Sprafka, J.M. (2009). Study of adverse outcomes in women using testosterone therapy. Maturitas, 62, 76-80.
135. Vermeulen, A. (2005). Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. Journal of Endocrinological Investigation, 28, 28-31.
136. Veronelli, A., Mauri, C., Zecchini, B., Peca, M.G., Turri, O., Valitutti, M.T., et al. (2009). Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A preliminary report. Journal of Sexual Medicine, 6, 1561-1568.
137. Walters, K.A., Allan, C.M., & Handelsman, D.J. (2008). Androgen actions and the ovary. Biology of Reproduction, 78, 380-389.
138. Wang, C., Catlin, D.H., Demers, L.M., Starcevic, B., & Swerdloff, R.S. (2004). Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 89, 534-543.
139. Wang, C., Nieschlag, E., Swerdloff, R.S., Behre, H., Hellstrom, W.J., Gooren, L.J., et al. (2009). ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. The Aging Male, 12, 5-12.
140. Wang, C., Plymate, S., Nieschlag, E., & Paulsen, C.A. (1981). Salivary testosterone in men: further evidence of a direct correlation with free serum testosterone. Journal of Clinical Endocrinology and Metabolism, 53, 1021-1024.
141. Warnock, J.K., Swanson, S.G., Borel, R.W., Zipfel, L.M., & Brennan, J.J. (2005). Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women. Menopause, 12, 374-384.
142. Weil, S., Vendola, K., Zhou, J., & Bondy, C.A. (1999). Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. Journal of Clinical Endocrinology and Metabolism, 84, 2951-2956.
143. Wierman,M.E., Basson, R., Davis, S.R., Khosla, S., Miller, K.K., Rosner, W., et al. (2006). Androgen therapy in women: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91, 3697-3710.
144. Wierman, M.E., Nappi, R.E., Avis, N., Davis, S.R., Labrie, F., Rosner, W., et al. (2010). Endocrine aspects of womens sexual function. Journal of Sexual Medicine, 7, 561-585.
145. World Health Organization. (1999). WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th ed. Cambridge: Cambridge University Press.
146. Wu, F.C., Tajar, A., Beynon, J.M., Pye, S.R., Silman, A.J., Finn, J.D., et al. (2010). Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine, 363, 123-135.
147. Wylie, K.R., & Davies-South, D. (2004). A study of treatment choices in men with erectile dysfunction and reduced androgen levels. Journal of Sex & Marital Therapy, 30, 107-114.
148. Wylie, K.R., & Hallam-Jones, R. (2009). Inhibited arousal in women. Journal of Family Psychotherapy, 20, 150-176.
149. Wylie, K.R., & Malik, F. (2009). A review of drug treatment for female sexual dysfunction. International Journal of STD & AIDS, 20, 671-674.
150. Zitzmann, M., & Nieschlag, E. (2007). Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 92, 3844-3853.